Nurseta, T., Harnandari, D.E.P., Herliawati, P.A., Nooryanto, M. and Handayani, P. 2021. Risk Of Malignancy Index 4 Performance as a Predictor Advanced Stage Epithelial Ovarian Carcinoma Used for Neoadjuvant Chemotherapy. Medical Laboratory Technology Journal. 7, 2 (Dec. 2021), 101–111. DOI:https://doi.org/10.31964/mltj.v0i0.394.